Figure 1From: Biomarkers for determining the prognosis in chronic myelogenous leukemiaTranscript levels predict survival outcomes. Eight-year probability of OS for patients stratified by risk group defined by transcript levels at 3 months (high-risk BCR-ABL1/ABL1 ratio > 9.84% [n = 68; gray line]; low-risk BCR-ABL1/ABL1 ≤ 9.84% [n = 211; black line]). From Marin et al. [51] (reproduced with permission).Back to article page